Recent News for ORMP - Oramed Pharmaceuticals Inc.

Date Title
Jun 19 ORMP: Positive Takeaways of Preliminary NASH Study Findings
Jun 15 Oramed Announces Positive Initial Clinical Trial Results for Treatment of NASH With Oral Insulin
Jun 12 The Daily Biotech Pulse: FDA Nod For Viela, 3 IPOs And Hematology Congress Presentations
Jun 9 Newsflash: Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Analysts Have Been Trimming Their Revenue Forecasts
Jun 7 The Week Ahead In Biotech: Viela FDA Decision, Hematology Conference Take Center Stage
Jun 4 Oramed Pharmaceuticals Inc. (ORMP): Are Hedge Funds Right About This Stock?
May 5 Will Oramed Pharmaceuticals (NASDAQ:ORMP) Spend Its Cash Wisely?
May 5 Oramed Pharmaceuticals to Present at the 80th American Diabetes Association Scientific Session, to be Held Virtually This Year in June
Apr 14 ORMP: Second quarter financial results; Strengthens Advisory Board; Positive EoP2 meeting with the FDA
Apr 7 Oramed Patent in Canada Allowed for Oral Delivery of Proteins
Apr 1 Oramed Pharmaceuticals Issues CEO Shareholder Letter Providing Business Update Amid COVID-19
Mar 30 Does Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Have A Particularly Volatile Share Price?
Mar 20 111 Biggest Movers From Yesterday
Mar 19 92 Stocks Moving In Thursday's Mid-Day Session
Mar 19 Oramed up 7% premarket on advancement of oral insulin
Mar 19 Oramed Receives Positive Feedback From End-of-Phase 2 Oral Insulin CMC Meeting With FDA
Mar 11 ORMP: Oramed announces positive results from cohort 2 of Phase 2 trial with ORMD-0801 in T2D patients
Feb 28 140 Biggest Movers From Yesterday
Feb 27 Diagnosis: Volatility — Every Coronavirus-Related Stock That Was Halted For Trading Today
Feb 27 Oramed Pharmaceuticals Inc. Prices Public Offering of Common Stock for Aggregate Proceeds of $21 Million
Feb 27 The Daily Biotech Pulse: Gilead Kicks Off Coronavirus Drug Trials, Adcom Nod For Lily, FDA Approves Esperion's Lipid-Lowering Adjunctive Combo Therapy
Feb 26 Oramed Pharmaceuticals Inc. Announces Proposed Public Offering of Common Stock
Feb 26 Oramed Reports Positive Results in the Final Cohort of Its Phase 2b Oral Insulin Trial
Feb 20 FDA implements new rule aimed at boosting competition in insulin
Feb 12 Have Insiders Been Buying Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Shares This Year?

Back to the Main ORMP Page...